Literature DB >> 33656983

Prevalence, risk correlates, and health comorbidities of insomnia in US military veterans: results from the 2019-2020 National Health and Resilience in Veterans Study.

Simon P Byrne1, Elissa McCarthy2, Jason C DeViva3,4, Steven M Southwick4, Robert H Pietrzak3,4,5.   

Abstract

STUDY
OBJECTIVES: Veterans experience high levels of trauma, psychiatric, and medical conditions that may increase their risk for insomnia. To date, however, no known study has examined the prevalence, risk correlates, and comorbidities of insomnia in a nationally representative sample of veterans.
METHODS: A nationally representative sample of 4,069 US military veterans completed a survey assessing insomnia severity; military, trauma, medical, and psychiatric histories; and health and psychosocial functioning. Multivariable analyses examined the association between insomnia severity, psychiatric and medical comorbidities, suicidality, and functioning.
RESULTS: A total of 11.4% of veterans screened positive for clinical insomnia and 26.0% for subthreshold insomnia. Greater age and retirement were associated with a lower likelihood of insomnia. Adverse childhood experiences, traumatic life events, lower education and income were associated with greater risk for insomnia. A "dose-response" association was observed for health comorbidities, with increasing levels of insomnia associated with elevated odds of psychiatric and medical conditions (clinical vs no insomnia odds ratio = 1.8-13.4) and greater reductions in health and psychosocial functioning (clinical vs no insomnia Cohen's d = 0.2-0.4). The prevalence of current suicidal ideation was 3-5 times higher in veterans with clinical and subthreshold insomnia relative to those without insomnia (23.9% and 13.6% vs 4.5%, respectively).
CONCLUSIONS: Nearly 2 in 5 US veterans experience clinical or subthreshold insomnia, which is associated with substantial health burden and independent risk for suicidal ideation. Results underscore the importance of assessment, monitoring, and treatment of insomnia in veterans as they transition from the military.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  anxiety; insomnia; posttraumatic stress disorder; trauma; veterans

Mesh:

Year:  2021        PMID: 33656983      PMCID: PMC8314657          DOI: 10.5664/jcsm.9182

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.324


  52 in total

1.  Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment.

Authors:  Karen H Seal; Greg Cohen; Angela Waldrop; Beth E Cohen; Shira Maguen; Li Ren
Journal:  Drug Alcohol Depend       Date:  2011-01-31       Impact factor: 4.492

2.  Ecological momentary assessment of sleep and PTSD symptoms in a veteran sample.

Authors:  Jason C DeViva; Marc I Rosen; Ned L Cooney; Anne C Black
Journal:  Psychol Trauma       Date:  2019-07-22

3.  Psychometric properties of a brief measure of posttraumatic stress disorder-related impairment: The Brief Inventory of Psychosocial Functioning.

Authors:  Sarah E Kleiman; Michelle J Bovin; Shimrit K Black; Paola Rodriguez; Laurel G Brown; Meaghan E Brown; Carole A Lunney; Frank W Weathers; Paula P Schnurr; James Spira; Terence M Keane; Brian P Marx
Journal:  Psychol Serv       Date:  2018-10-08

4.  Sleep problems outperform depression and hopelessness as cross-sectional and longitudinal predictors of suicidal ideation and behavior in young adults in the military.

Authors:  Jessica D Ribeiro; James L Pease; Peter M Gutierrez; Caroline Silva; Rebecca A Bernert; M David Rudd; Thomas E Joiner
Journal:  J Affect Disord       Date:  2011-10-26       Impact factor: 4.839

5.  The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response.

Authors:  Charles M Morin; Geneviève Belleville; Lynda Bélanger; Hans Ivers
Journal:  Sleep       Date:  2011-05-01       Impact factor: 5.849

6.  Loss of consciousness, depression, posttraumatic stress disorder, and suicide risk among deployed military personnel with mild traumatic brain injury.

Authors:  Craig J Bryan; Tracy A Clemans; Ann Marie Hernandez; Michael David Rudd
Journal:  J Head Trauma Rehabil       Date:  2013 Jan-Feb       Impact factor: 2.710

7.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

8.  Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial.

Authors:  Helen Christensen; Philip J Batterham; John A Gosling; Lee M Ritterband; Kathleen M Griffiths; Frances P Thorndike; Nick Glozier; Bridianne O'Dea; Ian B Hickie; Andrew J Mackinnon
Journal:  Lancet Psychiatry       Date:  2016-01-28       Impact factor: 27.083

9.  "Sleep disparity" in the population: poor sleep quality is strongly associated with poverty and ethnicity.

Authors:  Nirav P Patel; Michael A Grandner; Dawei Xie; Charles C Branas; Nalaka Gooneratne
Journal:  BMC Public Health       Date:  2010-08-11       Impact factor: 3.295

Review 10.  Sleep in the United States Military.

Authors:  Allison J Brager; Vincent F Capaldi; Vincent Mysliwiec; Cameron H Good
Journal:  Neuropsychopharmacology       Date:  2019-06-11       Impact factor: 7.853

View more
  2 in total

1.  The association of polysomnographic sleep on posttraumatic stress disorder symptom clusters in trauma-exposed civilians and veterans.

Authors:  Janeese A Brownlow; Katherine E Miller; Richard J Ross; Holly Barilla; Mitchel A Kling; Seema Bhatnagar; Thomas A Mellman; Philip R Gehrman
Journal:  Sleep Adv       Date:  2022-08-11

2.  New-onset and exacerbated insomnia symptoms during the COVID-19 pandemic in US military veterans: A nationally representative, prospective cohort study.

Authors:  Elissa McCarthy; Jason C DeViva; Peter J Na; Robert H Pietrzak
Journal:  J Sleep Res       Date:  2021-07-30       Impact factor: 5.296

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.